Tyme To Present Prostate Cancer Data From Its Ongoing Phase II Trial For SM-88 At Post author:Sam Post published:August 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints July 26, 2017 5 Biotechs Quietly Hitting Unusual Volumes Right Now June 22, 2017 Founding CEO of Editas Medicine Lands New Gig at Top Biotech VC Firm May 31, 2017